Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation()

Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and dose-limiting side effect of cancer treatment that affects millions of cancer survivors throughout the world and current treatment options are extremely limited by their side effects. Cannabinoids are highly effective in suppressing p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuropharmacology
Auteurs principaux: Mulpuri, Yatendra, Marty, Vincent N., Munier, Joseph J., Mackie, Ken, Schmidt, Brian L., Seltzman, Herbert H., Spigelman, Igor
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883926/
https://ncbi.nlm.nih.gov/pubmed/29981335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2018.07.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires